Can oxygen chambers boost heart failure treatment?
NCT ID NCT07311109
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether adding hyperbaric oxygen therapy (breathing pure oxygen in a pressurized chamber) to standard heart failure medications can help people with chronic heart failure walk farther and improve heart function. About 150 adults with reduced heart pumping ability will be randomly assigned to receive either standard drugs alone or standard drugs plus oxygen sessions. The main goal is to see if the oxygen therapy safely increases walking distance in six minutes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEART FAILURE WITH REDUCED EJECTION FRACTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Fujian Medical University Union Hospital
Fuzhou, Fujian, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart failure drug puzzle: study aims to untangle polypharmacy risks
- Salt pills for heart failure? new study investigates
- Smartphone app may help heart failure patients get the right meds faster
- Which workout is best for heart failure? new study aims to find out
- Could a common steroid speed heart shock recovery?
- Smart alerts aim to cut heart failure hospital stays